论文部分内容阅读
近年来,前列腺特异抗原(PSA)作为一种前列腺癌(PC)诊断和监测复发的肿瘤标志物已广泛用于临床。然而其特异性不能令人满意,因为一些良性前列腺病变患者血清PSA也可呈一定程度升高,易于同前列腺癌相混淆。本文收集1994~1998年本院泌尿外科门诊及住院病人中资料较完整的96例前列腺癌及226例良性前列腺增生(BPH)患者血清PSA含量进行分析,探讨其对前列腺病变诊断、鉴别
In recent years, prostate-specific antigen (PSA) has been widely used clinically as a tumor marker for the diagnosis and monitoring of recurrence of prostate cancer (PC). However, its specificity is not satisfactory, because some patients with benign prostatic diseases serum PSA can also be increased to some extent, easily confused with prostate cancer. This article collected from 1994 to 1998 in our hospital urology clinic and inpatient data more complete 96 cases of prostate cancer and 226 cases of benign prostatic hyperplasia (BPH) in patients with serum PSA levels were analyzed to explore the diagnosis of prostate lesions, identification